The survival rate of cells incubated with the ENO1 inhibitor decreased in a time- and dose-dependent manner compared to that of empty transfected cells without inhibitors (all P < 0.05), implying that ENO1 inhibition can inhibit hepatoma cell proliferation (Fig 8). This evidence concerns the gene ENO1 and hepatocellular carcinoma.